Results 301 to 310 of about 1,772,404 (331)
Ascitic fluid concentrations of fibronectin and cholesterol [PDF]
Gerbes, Alexander L.+3 more
core
Association between allopurinol and hepatocellular carcinoma: analysis of genetic risk and patient survival. [PDF]
Li YF+6 more
europepmc +1 more source
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma. [PDF]
Song Y+13 more
europepmc +1 more source
Detection of Genetic Variants in Thai Population by Trio-Based Whole-Genome Sequencing Study. [PDF]
Boonin P+6 more
europepmc +1 more source
The Prognostic Value and Immunomodulatory Role of Spsb2, a Novel Immune Checkpoint Molecule, in Hepatocellular Carcinoma. [PDF]
Tian L, Wang Y, Guan J, Zhang L, Fan J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Gastroenterology, 2003
The number of papers published in the topic of hepatocellular carcinoma (HCC) increased remarkably from last year. The prevalence of chronic hepatitis C infection has increased the incidence of HCC. However, studies confirm that obesity and nonalcoholic fatty liver disease are important factors for the development of HCC in the United States.
Josep M, Llovet+2 more
openaire +7 more sources
The number of papers published in the topic of hepatocellular carcinoma (HCC) increased remarkably from last year. The prevalence of chronic hepatitis C infection has increased the incidence of HCC. However, studies confirm that obesity and nonalcoholic fatty liver disease are important factors for the development of HCC in the United States.
Josep M, Llovet+2 more
openaire +7 more sources
Changing epidemiology of hepatocellular carcinoma in Asia
Liver international (Print), 2022Liver cancer is the fifth most common cancer and the second leading cause of malignant death in Asia, and Asia reports 72.5% of the world's cases in 2020.
Chen-Hao Zhang+4 more
semanticscholar +1 more source
The Lancet, 1999
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources